Table 3.
Prescription patterns of anti-asthmatic medications based on hospital levels.
| Prescription | Case (n = 267) | Control (n = 1035) | p values |
|---|---|---|---|
| SABA total | 4181 | 7049 | <0.0001 |
| Medical center | 682 (16.3) | 976 (13.8) | |
| Regional hospital | 1379 (33.0) | 2217 (31.5) | |
| District hospital | 1662 (39.8) | 2082 (29.5) | |
| Clinic | 458 (11.0) | 1774 (25.2) | |
| OCS total | 1769 | 2821 | <0.0001 |
| Medical center | 214 (12.1) | 418 (14.8) | |
| Regional hospital | 750 (42.4) | 1119 (39.7) | |
| District hospital | 655 (37.0) | 618 (21.9) | |
| Clinic | 150 (8.5) | 666 (23.6) | |
| ICS totala | 286 | 1326 | <0.0001 |
| Medical center | 55 (19.2) | 500 (37.7) | |
| Regional hospital | 153 (53.5) | 548 (41.3) | |
| District hospital | 60 (21.0) | 191 (14.4) | |
| Clinic | 18 (6.3) | 87 (6.6) |
Data were reported as numbers (%).
SABA short-acting β2-agonist, OCS oral corticosteroid, ICS inhaled corticosteroid.
aPrescription numbers were the sum of ICS monotherapy and the fixed-drug combination of ICS and the long-acting β2-agonist.